Circulating Tumor Cells (CTC) in Lung Cancer

Running, not enrolling

Conditions studied: Lung Neoplasms

In brief

The primary objective of this study is to establish circulating tumor cell (CTC) derived xenografts and assess the activity of novel DNA repair inhibitors as a function of DNA repair mutations detected in CTC samples (personalize DNA repair therapy).

Key facts

Study ID

NCT02630615

Run by

Shadia Jalal

People needed

80

Starts

2017-10-19

Expected to finish

2026-10-01

Last updated by the study team

2026-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Indiana University Health Melvin and Bren Simon Cancer Center — Indianapolis, Indiana, United States
• Roudebush VA Medical Center — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.